David Wurtman is an entrepreneurial leader with a Harvard M.D. and MIT Sloan M.B.A., specializing in enhancing the value of biopharma assets and companies.

He has held CEO and CMO positions, bringing a unique blend of strategic operational skills, technical expertise, clinical knowledge, market insights, transactional proficiency, and product innovation to drive the development of projects that add substantial value.

David is known for his articulate and passionate presentation style, coupled with creative problem-solving abilities and a tenacious approach to challenges.

His professional experience includes serving as the Chief Medical Officer at Lucid Diagnostics, CEO at Lyric Pharmaceuticals Inc., VP of Product Development & Medical Affairs at Kineta, Inc., and VP of Corporate Development at Ansun Biopharma, Inc.